Dexamfetamine 5 mg: Noumed is your new brand
Between 1 January and 1 June 2024, your brand of dexamfetamine will change. The new brand will look different, but the tablets have the same active ingredient.
8 December 2023
Noumed Dexamfetamine has been announced as the new brand of dexamfetamine. It will be listed from 1 January 2024
Noumed: Same active ingredient, works the same way
The Noumed product has the same active ingredient as the Aspen product. Noumed is identical to the PSM branded dexamfetamine which was funded in New Zealand before July 2022.
The active ingredient in all products remains the same, in the same quantity and works in your body the same way.
What's changed?
The tablets and packaging will look different. Some of the excipients (non-active ingredients) are also different. The Medsafe Datasheet for each brand lists all the excipients.
Why is this happening?
The previous supplier, API, left the New Zealand market. We sourced a short-term supply of the Aspen brand dexamfetamine so people could continue to access their medicine.
We have now secured long-term supply of dexamfetamine sulfate 5 mg tablets, through the Pharmac tender process.
Key dates
1 January 2024: Noumed Dexamfetamine brand listed in the Pharmaceutical Schedule
1 June 2024: Aspen Dexamfetamine delisted and no longer funded
1 June 2024: Brand switch fee delisted
Who to contact?
If you have any questions or concerns about this change, talk with your doctor, nurse or pharmacist.
You can also get more information from us at enquiry@pharmac.govt.nz or 0800 660 050